Heska Medical Heska Corporation (NASDAQ: HSKA) was founded in 1988, formerly known as Paravax, Inc., and changed to its current name in 1995. Headquartered in Loveland, Colorado, USA, with 310 full-time employees, it is a company in the United States and Europe. And internationally, a veterinary product company that develops, manufactures, markets, sells and supports the health market for dogs and cats and other companion animals.
Heska Corporation (HSKA):
Heska Corporation is divided into 2 divisions to operate: Core Companion Animal Health, Other Vaccines, and Pharmaceuticals and Products.
- Core Companion Animal Health ——Provide Element DC and DRI-CHEM 7000 veterinary chemistry analyzers for blood chemistry and electrolyte analysis; HT5 and HEMATRUE veterinary blood analyzers to operate and measure animal white blood cell count, red blood cell count, platelet count and hemoglobin ; Element POC blood gas and electrolyte analyzer; Element i immunodiagnostic analyzer; IV pump; The department also provides veterinary imaging equipment and services, such as digital radiography solutions and ultrasound systems, and sells mobile digital radiography products; cats and dogs heart Filaria diagnostic test products; TRI-HEART Plus Chewable Tablets, used to prevent heartworm infection in dogs, and treat and control roundworm and hookworm infections; allergy products and services, including ALLERCEPT clear allergen panels.
- Other Vaccines, and Pharmaceuticals and Products -provide bovine vaccines; biological and pharmaceutical products for other animal health companies; various turnkey services, including research, licensing, production, labeling and packaging, and provision of verification support and distribution services.
Heska Medical sells its products to veterinarians through direct sales, telemarketing teams and independent third-party distributors, as well as trade shows, print ads and other distribution relationships.